Detalhe da pesquisa
1.
Targeting OCT3 attenuates doxorubicin-induced cardiac injury.
Proc Natl Acad Sci U S A
; 118(5)2021 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495337
2.
A novel transcription factor combination for direct reprogramming to a spontaneously contracting human cardiomyocyte-like state.
J Mol Cell Cardiol
; 182: 30-43, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421991
3.
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity.
Circulation
; 145(4): 279-294, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34874743
4.
Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.
Annu Rev Pharmacol Toxicol
; 58: 83-103, 2018 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28992430
5.
Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report.
Cancer
; 126(17): 4051-4058, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32413235
6.
CD14 Blockade Does Not Improve Outcomes of Deep Vein Thrombosis Following Inferior Vena Cava Stenosis in Mice.
bioRxiv
; 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38260582
7.
Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes.
JACC CardioOncol
; 6(1): 38-50, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38510289
8.
Interactions between integrin α9ß1 and VCAM-1 promote neutrophil hyperactivation and mediate poststroke DVT.
Blood Adv
; 8(9): 2104-2117, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498701
9.
PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation.
Nucleic Acids Res
; 39(12): 5284-98, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21345932
10.
A Novel Transcription Factor Combination for Direct Reprogramming to a Spontaneously Contracting Human Cardiomyocyte-like State.
bioRxiv
; 2023 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36993577
11.
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report.
J Am Heart Assoc
; 12(19): e029954, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37750583
12.
Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy.
Sci Rep
; 13(1): 12683, 2023 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37542143
13.
Use of hiPSC to explicate genomic predisposition to anthracycline-induced cardiotoxicity.
Pharmacogenomics
; 22(1): 41-54, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33448871
14.
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy.
Cell Stem Cell
; 28(12): 2076-2089.e7, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525346
15.
Human In Vitro Models for Assessing the Genomic Basis of Chemotherapy-Induced Cardiovascular Toxicity.
J Cardiovasc Transl Res
; 13(3): 377-389, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078739
16.
Precise and Cost-Effective Nanopore Sequencing for Post-GWAS Fine-Mapping and Causal Variant Identification.
iScience
; 23(4): 100971, 2020 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32203907
17.
Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture.
Stem Cell Reports
; 14(2): 256-270, 2020 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31928950
18.
Unraveling Difficult Answers: From Genotype to Phenotype in Coronary Artery Disease.
Cell Stem Cell
; 24(2): 203-205, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30735646
19.
Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022.
Front Pharmacol
; 14: 1172265, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36937855
20.
Prime time for doxorubicin-induced cardiotoxicity genetic testing.
Pharmacogenomics
; 23(6): 335-338, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380470